AIDS Archives -

Researchers discovered a highly virulent variant of HIV in the Netherlands that genetic sequence analysis suggests has been

New HIV variant highlights the importance of monitoring virus mutations

https://pharmaphorum.com/r-d/new-hiv-variant-highlights-the-importance-of-monitoring-virus-mutations/

Patients/ Views & Analysis/ Views and analysis

Addressing the HIV epidemic in Eastern Europe and Central Asia

mike.hammerton@pharmaphorum.com AIDS, asia, Eastern Europe, Elton John AIDS Foundation, Gilead, HIV, RADIAN 0 Comment

Working in partnership will be key, says Alex Kalomparis, vice president, public affairs, international at Gilead Sciences. 2021

Addressing the HIV epidemic in Eastern Europe and Central Asia

https://pharmaphorum.com/patients/gilead-hiv-epidemic-eastern-europe-central-asia/

Patients/ Views & Analysis/ Views and analysis

Finding resilience after an HIV diagnosis

George Underwood AIDS, HIV, patient insights 0 Comment

Author and journalist John-Manuel Andriote has spent much of his career writing about the impact of HIV/AIDS –

Finding resilience after an HIV diagnosis

https://pharmaphorum.com/views-analysis-patients/finding-resilience-hiv-diagnosis/

pharmaphorum podcast with IAVI on global health challenges

Podcast/ R&D/ Views & Analysis/ Views and analysis

Addressing global health challenges: the pharmaphorum podcast

Dominic Tyer AIDS, HIV, IAVI, podcast, public health, tuberculosis, vaccines 0 Comment

For episode 11 of the pharmaphorum podcast our CEO and founder Dr Paul Tunnah took the helm to

Addressing global health challenges: the pharmaphorum podcast

https://pharmaphorum.com/r-d/iavi-hiv-tuberculosis-pharma-podcast/

Market Access/ News/ News

MPs call for NHS funding for HIV prevention drug

Richard Staines AIDS, HIV, PrEP 0 Comment

Leading UK politicians have called for an HIV prevention drug to be made available across the NHS, after

MPs call for NHS funding for HIV prevention drug

https://pharmaphorum.com/news/mps-call-for-nhs-funding-for-hiv-truvada/

Gilead/ News/ UK & Europe

NHS England confirms HIV prevention funding – but only via clinical trial

Richard Staines AIDS, Gilead, HIV, PrEP 0 Comment

Large trial of HIV PrEP could lead to national programme

NHS England confirms HIV prevention funding – but only via clinical trial

https://pharmaphorum.com/news/nhs-england-extend-hiv-prevention-programme/

Articles/ Healthcare/ Views and analysis

A true story: Living with AIDS

Marco Ricci AIDS, patient experience, patients, World AIDS Day 0 Comment

A 50-year-old man relates his personal experience of living with the condition.

A true story: Living with AIDS

https://pharmaphorum.com/views-and-analysis/true-story-living-aids/

Gilead/ News/ UK & Europe

UK court victory for access to HIV prevention drug

Richard Staines AIDS, Gilead, HIV, litigation, PrEP, prevention 0 Comment

Court ruling paves way for decision on PrEP.

UK court victory for access to HIV prevention drug

https://pharmaphorum.com/news/nhs-make-decision-gilead-hiv-prevention-drug/

News/ R&D/ UK & Europe

Gilead’s next gen HIV prevention trial to begin in UK

Richard Staines AIDS, Gilead, HIV, pre-exposure prophylaxis, R&D 0 Comment

UK hospital seeking ethical clearance for trial of Gilead’s new PReP drug.

Gilead’s next gen HIV prevention trial to begin in UK

https://pharmaphorum.com/news/new-hiv-prep-trial-poised-begin-uk/

Trending

AIDS

Login